Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells

30 Jan 2016

Abstract excerpt

// Maria C. Palanca-Wessels 1, 2, * , Garrett C. Booth 1 , Anthony J. Convertine 3 , Brittany B. Lundy 3 , Geoffrey Y. Berguig 3 , Michael F. Press 4 , Patrick S. Stayton 3 , Oliver W. Press 1, 3 1 Clinical Research Division and Center for Intracellular Delivery of Biologics, Fred Hutchinson Cancer Research Center, Seattle, WA, USA 2 Department of Medicine, Hematology Division, University of Washington, Seattle,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced biosensing and bioanalysis techniques
Share to Monoclonal and Polyclonal Antibodies Research
Share to RNA Interference and Gene Delivery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26840082
DOI: 10.18632/oncotarget.7076

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cellsPMID 26840082Read ↗

Exploring the Potentials of Antibody–siRNA Conjugates in Tumor Cell Gene Silencing without Cationic AssistanceSemantic proximity Read ↗

mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In VivoSemantic proximity Read ↗

Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cellsSemantic proximity Read ↗

Exosomes containing miRNAs targeting HER2 synthesis and engineered to adhere to HER2 on tumor cells surface exhibit enhanced antitumor activitySemantic proximity Read ↗

Bioactivity of Recombinant Humanized Monoclonal Antibody Against HER2 and Its Mechanism of Action on Ovarian CancerSemantic proximity Read ↗

Enhancing Breast Cancer Therapy: Nanocarrier-Based Targeted Drug DeliverySemantic proximity Read ↗

Targeted Delivery of siRNA through Nanocomplex using Specific Fusion Peptides for Breast Cancer TreatmentSemantic proximity Read ↗

Targeted Nanoparticles: an Innovative Modality in the Treatment of CancerSemantic proximity Read ↗

Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and OncologySemantic proximity Read ↗

Bispecific antibody targeting of lipid nanoparticlesSemantic proximity Read ↗

Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamersSemantic proximity Read ↗

Downregulation of PIK3CA via antibody-esiRNA-complexes suppresses human xenograft tumor growth.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.